TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Quercitrin, Insulin
Phytochemical Name Quercitrin (PubChem CID: 5280459 )
Anticancer drug Name Insulin (PubChem CID: 16131098 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 459
Pair Name Quercitrin, Insulin
Disease Info [ICD-11: 5A80] Polycystic ovary syndrome Investigative
Gene Regulation Up-regulation Phosphorylation AKT1 hsa207
Up-regulation Phosphorylation MTOR hsa2475
Up-regulation Phosphorylation PIK3CA hsa5290
Up-regulation Expression PM20D1 hsa148811
Up-regulation Phosphorylation PRKAA1 hsa5562
In Vitro Model 3T3-L1 Healthy Mus musculus (Mouse) CVCL_0123
In Vivo Model A total of 48 (specific pathogen-free) SPF female Sprague Dawley rats (aged from six weeks, body weight of 130 –150 g) were uesd in study.
Result PM20D1 and PI3K/Akt were required for lipolysis and endocrine regulation in PCOS-IR to restore ovarian function and maintain normal endocrine metabolism. By upregulating the expression of PM20D1, quercitrin activated the PI3K/Akt signaling pathway, improved adipocyte catabolism, corrected reproductive and metabolic abnormalities, and had a therapeutic effect on PCOS-IR.
03. Reference
No. Title Href
1 Quercitrin alleviates lipid metabolism disorder in polycystic ovary syndrome-insulin resistance by upregulating PM20D1 in the PI3K/Akt pathway. Phytomedicine. 2023 Aug;117:154908. doi: 10.1016/j.phymed.2023.154908. Click
It has been 48470 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP